What is Complexa?
Complexa Inc. operates within the biopharmaceutical sector, specifically focusing on the development of novel therapeutics for debilitating fibrotic and inflammatory conditions. The company's clinical-stage status indicates a focus on advancing drug candidates through rigorous testing and regulatory pathways. Its commitment to addressing severe diseases positions it as a key player in a critical area of unmet medical need.
How much funding has Complexa raised?
Complexa has raised a total of $90.1M across 10 funding rounds:
Private Equity
$2M
Series A
$3.6M
Debt
$1.4M
Private Equity
$200K
Series B
$14.8M
Debt
$4M
Debt
$950K
Debt
$1M
Series C
$62M
Debt
$150K
Private Equity (2012): $2M, investors not publicly disclosed
Series A (2012): $3.6M led by Pittsburgh Life Sciences Greenhouse
Debt (2013): $1.4M, investors not publicly disclosed
Private Equity (2013): $200K featuring Pittsburgh Life Sciences Greenhouse
Series B (2014): $14.8M backed by Pittsburgh Life Sciences Greenhouse
Debt (2015): $4M, investors not publicly disclosed
Debt (2016): $950K, investors not publicly disclosed
Debt (2016): $1M, investors not publicly disclosed
Series C (2017): $62M featuring JAFCO, Edmond de Rothschild Investment Partners, New Enterprise Associates, and HBM Healthcare Investments
Debt (2020): $150K backed by PPP
Key Investors in Complexa
JAFCO
JAFCO Group Co., Ltd. specializes in venture investments aimed at startups that challenge the creation of new businesses, as well as buyout investments targeting small to medium-sized enterprises seeking to achieve re-growth. The company has been supporting diverse challenges alongside entrepreneurs since its establishment in 1973. JAFCO focuses on fueling continuous business growth through bold investments and concentrated management involvement. Their investment strategy is designed to enhance sustainable value for companies entering new stages of development.
Edmond de Rothschild Investment Partners
Edmond de Rothschild, founded in 1923 and headquartered in France, is an investment banking firm offering various financial services and solutions.
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California. New Enterprise Associates(NEA) is a venture capital firm focused on helping entrepreneurs build businesses.
What's next for Complexa?
With a substantial funding history, Complexa is poised for accelerated growth and the advancement of its therapeutic pipeline. The recent strategic investment, coupled with its overall capital base of $90.1M, suggests a strong investor confidence in the company's scientific approach and market potential. This financial backing will likely fuel further research and development, clinical trial progression, and potential commercialization efforts, aiming to bring innovative treatments to patients suffering from fibrosis and inflammatory diseases.
See full Complexa company page
